The Power of Mentoring Others With Lymphoma | MyLymphomaTeam

Connect with others who understand.

sign up Log in
Resources
About MyLymphomaTeam
Powered By

The Power of Mentoring Others With Lymphoma

Written by Lisa Wu
Posted on November 20, 2020

Having any type of cancer can be tough, but working through those challenges with others can make the journey a little less difficult. Here at MyLymphomaTeam, we’re driven by our mission to help people connect to those who understand.

We’re expanding the scope of our mission by partnering with Imerman Angels, a nonprofit organization that offers people with cancer, previvors, and caregivers from around the world the chance to connect with a Mentor Angel who has been through similar challenges.

Together, we believe we can change the way we live with lymphoma by guaranteeing that no one has to go through this journey alone.

About Imerman Angels

When Jonny Imerman was first diagnosed with cancer at age 26, he wasn’t sure who to talk to. Jonny had a valuable network of family and friends, but he wanted to speak with someone who had experience with his diagnosis and could offer personal advice for all the twists and turns of life with cancer.

Jonny began to imagine a program that creates one-on-one connections between people like him and those who have been in their shoes before. He founded Imerman Angels in 2003 for that purpose. Now, the Mentor Angels program is a centerpiece of Imerman Angels’ mission. The Mentor Angels are a diverse group of previvors, cancer survivors, and caregivers. Over 11,706 mentors and 28,659 mentees have participated worldwide (as of June 2020), and the program continues to grow.

Why Mentoring Matters

Both Imerman Angels and MyLymphomaTeam offer support for every individual, no matter where they are. Our missions complement each other, allowing those with cancer to both connect to a broader community and develop peer-to-peer relationships.

Social connections have been shown to improve overall health and longevity, especially as people age. Many mentors have found it extremely meaningful to pass the knowledge they’ve gained to others. For some, it’s become a huge part of their lives.

More than 40 criteria are used to match Mentor Angels with mentees, including demographic information, cancer history, and treatment. All information is kept confidential and is never shared with anyone except the person you agree to support.

Each potential mentor works with a staff member of Imerman Angels to get screened and trained.

“It has been very helpful and comforting to know that I can talk with my Mentor Angel,” said Ron, an Immeran Angels mentee with lymphoma. “It gives me an excellent opportunity to understand the upcoming possibilities of how to manage my cancer. Thank you so much for providing this service! I am very grateful to meet a Mentor Angel who is compassionate, informative, and helpful in my healing journey.”

Get Connected

To get started as an Angel Mentor — either as a cancer previvor, survivor, or caregiver — follow these seven steps:

  1. Visit imermanangels.org and click “become a mentor.”
  2. Fill out a brief online registration form.
  3. In one business day, an Imerman Angels representative will contact you.
  4. Start your Mentor Angels training. Imerman Angels will reach out when they find someone requesting support for the experiences you have shared.
  5. After you’ve been matched with a mentee, introduce yourself. From there on out, the two of you can set your own pace, whether it’s connecting via weekly conversations or just answering the occasional question.
  6. Keep the momentum going. Share MyLymphomaTeam as an additional resource to maintain engagement between calls.
  7. Three weeks after the match, you will receive a follow-up survey. You can also share how your connection is going with your match in the comments below to inspire others!
Posted on November 20, 2020
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest articles about lymphoma sent to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lisa Wu is pursuing a Bachelor of Science at Yale University in molecular, cellular, and developmental biology. Learn more about her here.

Recent Articles

Diffuse large B-cell lymphoma (DLBCL) is staged based on which lymph nodes and organs are involve...

Early vs. Advanced DLBCL: How Are They Treated Differently?

Diffuse large B-cell lymphoma (DLBCL) is staged based on which lymph nodes and organs are involve...
Roughly 50 percent to 60 percent of people relapse within the first two years of achieving remiss...

DLBCL Relapse Chances and Treatment Options

Roughly 50 percent to 60 percent of people relapse within the first two years of achieving remiss...
When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all of your detectabl...

Remission and Complete Response in DLBCL: How Long It Lasts and More

When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all of your detectabl...
The majority of people with diffuse large B-cell lymphoma (DLBCL) will live with their condition ...

DLBCL Prognosis: Fear, Hope, and Understanding Survival Rates

The majority of people with diffuse large B-cell lymphoma (DLBCL) will live with their condition ...
After successful treatment for diffuse large B-cell lymphoma (DLBCL), you’ll enter complete remis...

DLBCL Relapse: 4 Symptoms To Watch For

After successful treatment for diffuse large B-cell lymphoma (DLBCL), you’ll enter complete remis...
There are many risk factors, both inherited and environmental, believed to increase one’s risk of...

Is Diffuse Large B-Cell Lymphoma Inherited? Genetics and 8 Other Risk Factors

There are many risk factors, both inherited and environmental, believed to increase one’s risk of...
MyLymphomaTeam My lymphoma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close